Clinic
Northwest Spine and Pain Medicine, PLLC
Northwest Spine and Pain Medicine, PLLC was paid $1.97M by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoNORTHWEST SPINE AND PAIN MEDICINE, PLLC
SPOKANE, WA 99223
SPOKANE, WA 99223
33aNPI1669789228assigned 09/02/2010
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$1.97M
24GClaims93,972
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Washington
Rank by total paid#11 of 31
Median peer was paid$338K
This provider vs. median5.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,954 | $243K | |
| 2019 | 6,495 | $113K | |
| 2020 | 9,329 | $258K | |
| 2021 | 14,199 | $355K | |
| 2022 | 15,996 | $295K | |
| 2023 | 20,882 | $342K | |
| 2024incomplete | 19,117 | $368K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 31,238 | 24,187 | $549K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 27,892 | 16,931 | $520K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 13% | 6,393 | 4,999 | $264K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 9.8% | 2,041 | 1,727 | $193K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 5.2% | 1,475 | 1,180 | $102K |
| 95886 | 4.3% | 2,683 | 1,180 | $86K | |
| 95911 | 2.9% | 855 | 683 | $58K | |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.8% | 984 | 440 | $36K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.4% | 435 | 384 | $27K |
| 20553 | 1.3% | 1,354 | 1,044 | $25K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1.0% | 3,503 | 2,436 | $21K |
| 99152 | <1% | 1,555 | 1,133 | $16K |
26 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,639 | $16K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 69 | $8K |
| 64635 | <1% | 48 | $6K | |
| 99484 | <1% | 5,040 | $5K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 392 | $5K |
| 20552 | <1% | 199 | $5K | |
| 62323 | <1% | 91 | $4K | |
| 64636 | <1% | 48 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 75 | $3K |
| 64493 | <1% | 84 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 70 | $2K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 71 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 250 | $2K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 124 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 416 | $2K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 949 | $2K |
| 64494 | <1% | 84 | $1K | |
| 0012A | <1% | 28 | $1K | |
| 97162 | <1% | 32 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,127 | $963.44 |
| 0011A | <1% | 32 | $525.14 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 70 | $166.08 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,555 | $115.33 |
| 96150 | <1% | 16 | $101.68 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 33 | $11.35 |
| 82962 | <1% | 22 | $9.11 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEWIS, JAMIE (CEO)